journal article·2023-12-31Open access

Antiviral and antibacterial potential of electrosprayed PVA/PLGA nanoparticles loaded with chlorogenic acid for the management of coronavirus and Pseudomonas aeruginosa lung infection

Asmaa Saleh, Dalia H. Abdelkader, Thanaa A. El-Masry, Duaa Eliwa, Badriyah Alotaibi, Walaa A. Negm, Engy Elekhnawy

Abstract

Respiratory tract infections are a common cause of morbidity and mortality globally. The current paper aims to treat this respiratory disorder. Therefore, we elucidated the phytochemical profile of Euphorbia milii flowers and isolated chlorogenic acid (CGA) for the first time. The electrospraying technique was utilized to prepare CGA nanoparticles in polyvinyl alcohol (PVA)/PLGA polymeric matrix. Complete in vitro characterizations were performed to determine particle size, polydispersity index (PDI), zeta potential, loading efficiency (LE), scanning electron microscopy and in vitro release study. The optimum formula (F2) with a particle size (454.36 ± 36.74 nm), a surface charge (–4.56 ± 0.84 mV), % of LE (80.23 ± 5.74), an initial burst (29.46 ± 4.79) and % cumulative release (97.42 ± 4.72) were chosen for further activities. In the murine lung infection model, PVA/PLGA NPs loaded with CGA (F2) demonstrated in vivo antibacterial activity against Pseudomonas aeruginosa. Using a plaque assay, the in vitro antiviral activity was investigated. The F2 exhibited antiviral activity against coronavirus (HCoV-229E) and (Middle East respiratory syndrome coronavirus (MERS-CoV), NRCEHKU270). The IC50 of F2 against HCoV-229E and MERS-CoV was 170 ± 1.1 and 223 ± 0.88 µg/mL, respectively. The values of IC50 of F2 were significantly lower (p < .05) than that of free CGA. Therefore, the encapsulation of CGA into electrospray PVA/PLGA NPs would be a promising tool as an antimicrobial agent.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Electrohydrodynamics and Fluid Dynamics · Plant responses to water stress

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia

Department of Pharmaceutical Technology, College of Pharmacy, Tanta University, Tanta, Egypt

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta, Egypt

Department of Pharmacognosy, Faculty of Pharmacy, Tanta University, Tanta, Egypt

Pharmaceutical Microbiology Department, Faculty of Pharmacy, Tanta University, Tanta, Egypt

Funding

Deanship of Scientific Research at Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia, through the Research Groups Program

References (47)

Show source-provided references
1. 10.1016/S1473-3099(18)30310-410.1016/S1473-3099(18)30310-4 ↗
2. 10.3389/fpubh.2020.0025410.3389/fpubh.2020.00254 ↗
3. Pattemore PK, Jennings LC. Epidemiology of respiratory infections. Pediatr Respir Med. 2008;435.10.1016/B978-032304048-8.50035-9 ↗
4. Endres A · Front Cell Infect Microbiol · 2022 · 12 · 14310.3389/fcimb.2022.846828 ↗
5. Bayes H · Sci Rep · 2016 · 6 · 1010.1038/srep35838 ↗
6. 10.1016/j.ijantimicag.2020.10605410.1016/j.ijantimicag.2020.106054 ↗
7. 10.15171/jhp.2018.0110.15171/jhp.2018.01 ↗
8. Chassagne F · Front Pharmacol · 2021 · 11 · 206910.3389/fphar.2020.586548 ↗
9. 10.3390/antibiotics1003023110.3390/antibiotics10030231 ↗
10. 10.1016/j.phytochem.2019.03.02610.1016/j.phytochem.2019.03.026 ↗
11. 10.1016/j.jfoodeng.2006.06.03810.1016/j.jfoodeng.2006.06.038 ↗
12. 10.1016/j.ajps.2014.09.00510.1016/j.ajps.2014.09.005 ↗
13. 10.1093/jn/131.1.6610.1093/jn/131.1.66 ↗
14. Jaiswal R · Food Res Int · 2014 · 61 · 21410.1016/j.foodres.2013.09.040 ↗
15. 10.1016/j.carbpol.2017.04.07610.1016/j.carbpol.2017.04.076 ↗
16. 10.1002/pi.497210.1002/pi.4972 ↗
17. 10.1016/j.elstat.2007.10.00110.1016/j.elstat.2007.10.001 ↗
18. 10.1016/j.ijpharm.2016.01.04610.1016/j.ijpharm.2016.01.046 ↗
19. 10.1080/10717544.2022.208372510.1080/10717544.2022.2083725 ↗
20. 10.2147/IJN.S35860610.2147/IJN.S358606 ↗
21. Panda BP · Multidisc Digit Publ Inst Proc · 2020 · 78 · 14
22. 10.1016/j.jfca.2013.10.00510.1016/j.jfca.2013.10.005 ↗
23. 10.1016/j.indcrop.2009.07.00410.1016/j.indcrop.2009.07.004 ↗
24. 10.3390/pharmaceutics1310165810.3390/pharmaceutics13101658 ↗
25. Owusu-Ware SK · J Pharm Pharmacol · 2010 · 62 · 1357
26. 10.1016/j.immuni.2020.05.00410.1016/j.immuni.2020.05.004 ↗
27. Nallusamy S · Front Pharmacol · 2021 · 12 · 170410.3389/fphar.2021.667704 ↗
28. 10.3390/plants1008162110.3390/plants10081621 ↗
29. 10.1155/2018/204853010.1155/2018/2048530 ↗
30. 10.3390/ph1405042810.3390/ph14050428 ↗
31. 10.3390/ijms2206312810.3390/ijms22063128 ↗
32. 10.1016/j.jpha.2015.11.00510.1016/j.jpha.2015.11.005 ↗
33. 10.1007/978-1-0716-0211-9_1610.1007/978-1-0716-0211-9_16 ↗
34. 10.3390/ijms2205271910.3390/ijms22052719 ↗
35. Ács N · Front Microbiol · 2020 · 11 · 2662
36. Mendoza EJ · Curr Protoc Microbiol · 2020 · 57 · cpmc10510.1002/cpmc.105 ↗
37. 10.3390/molecules2704132910.3390/molecules27041329 ↗
38. 10.3390/polym1401014410.3390/polym14010144 ↗
39. 10.1016/j.ijpharm.2022.12210610.1016/j.ijpharm.2022.122106 ↗
40. 10.3390/ph1509105710.3390/ph15091057 ↗
41. van Hoek ML, Kaushal A, Bishop BM, et al. Intraperitoneal treatment with antimicrobial peptide rescues mice from a pulmonary Francisella infection. bioRxiv; 2019. p. 603233.10.1101/603233 ↗
42. 10.3390/ph1509104310.3390/ph15091043 ↗
43. 10.3390/md2011069410.3390/md20110694 ↗
44. Miotto A · Ital J Anat Embryol · 2009 · 114 · 193
45. 10.3390/ph1412131310.3390/ph14121313 ↗
46. 10.3390/antibiotics1012144410.3390/antibiotics10121444 ↗
47. 10.1021/acsomega.2c0486710.1021/acsomega.2c04867 ↗